Rheumatology in the Middle East in 2017: clinical challenges and research

The World Health Organization (WHO) has ranked musculoskeletal diseases among the top ten leading causes of disability in the Middle East. The situation in the Middle East is unique as, although seventeen countries are geographical connected, there is considerable variability in the standard of rheu...

Descripción completa

Detalles Bibliográficos
Autores principales: Watad, Abdulla, Al-Saleh, Jamal, Lidar, Merav, Amital, Howard, Shoenfeld, Yehuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493117/
https://www.ncbi.nlm.nih.gov/pubmed/28666485
http://dx.doi.org/10.1186/s13075-017-1359-0
_version_ 1783247448560369664
author Watad, Abdulla
Al-Saleh, Jamal
Lidar, Merav
Amital, Howard
Shoenfeld, Yehuda
author_facet Watad, Abdulla
Al-Saleh, Jamal
Lidar, Merav
Amital, Howard
Shoenfeld, Yehuda
author_sort Watad, Abdulla
collection PubMed
description The World Health Organization (WHO) has ranked musculoskeletal diseases among the top ten leading causes of disability in the Middle East. The situation in the Middle East is unique as, although seventeen countries are geographical connected, there is considerable variability in the standard of rheumatology care and research between the countries. There are several factors contributing to this variability: allocated government resources to healthcare services, country demographics, the implemented healthcare system, the number of qualified rheumatologist, political stability, and the immigration to and from these countries.
format Online
Article
Text
id pubmed-5493117
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54931172017-07-05 Rheumatology in the Middle East in 2017: clinical challenges and research Watad, Abdulla Al-Saleh, Jamal Lidar, Merav Amital, Howard Shoenfeld, Yehuda Arthritis Res Ther Commentary The World Health Organization (WHO) has ranked musculoskeletal diseases among the top ten leading causes of disability in the Middle East. The situation in the Middle East is unique as, although seventeen countries are geographical connected, there is considerable variability in the standard of rheumatology care and research between the countries. There are several factors contributing to this variability: allocated government resources to healthcare services, country demographics, the implemented healthcare system, the number of qualified rheumatologist, political stability, and the immigration to and from these countries. BioMed Central 2017-06-30 2017 /pmc/articles/PMC5493117/ /pubmed/28666485 http://dx.doi.org/10.1186/s13075-017-1359-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Watad, Abdulla
Al-Saleh, Jamal
Lidar, Merav
Amital, Howard
Shoenfeld, Yehuda
Rheumatology in the Middle East in 2017: clinical challenges and research
title Rheumatology in the Middle East in 2017: clinical challenges and research
title_full Rheumatology in the Middle East in 2017: clinical challenges and research
title_fullStr Rheumatology in the Middle East in 2017: clinical challenges and research
title_full_unstemmed Rheumatology in the Middle East in 2017: clinical challenges and research
title_short Rheumatology in the Middle East in 2017: clinical challenges and research
title_sort rheumatology in the middle east in 2017: clinical challenges and research
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493117/
https://www.ncbi.nlm.nih.gov/pubmed/28666485
http://dx.doi.org/10.1186/s13075-017-1359-0
work_keys_str_mv AT watadabdulla rheumatologyinthemiddleeastin2017clinicalchallengesandresearch
AT alsalehjamal rheumatologyinthemiddleeastin2017clinicalchallengesandresearch
AT lidarmerav rheumatologyinthemiddleeastin2017clinicalchallengesandresearch
AT amitalhoward rheumatologyinthemiddleeastin2017clinicalchallengesandresearch
AT shoenfeldyehuda rheumatologyinthemiddleeastin2017clinicalchallengesandresearch

Ejemplares similares